Treatments for the primary process of Alzheimers Disease

Treatments for the primary process of Alzheimers Disease

What treatments exist for the primary process of Alzheimers Disease? 

The Food and Drug Administration (FDA) has approved five treatments specifically for Alzheimers Disease.

Donepezil, rivastigmine, and galantamine are cholinesterase inhibitors, and memantine is an -methyl- d -aspartate receptor antagonist.

Studies of estrogen as a treatment for Alzheimers Disease have been negative.

Many patients can qualify for experimental studies of potential new Alzheimers Diseasetreatments and should be referred to Alzheimers Disease research centers that test medications if they are interested.

Available drugs and sites can be identified by calling the National Alzheimer’s Disease Association in Chicago or searching ClinTrials.Gov

You cannot copy content of this page